Drug Discovery Award
Funding Amount
Not stated
Deadline
Deadline not published
Grant Type
Foundation
Deadline history & next window
- Cycle
- Annual
- Tracked since
- April 2026
Source: the cycle recorded on this listing. Confirm dates with the funder.
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Geography
- No geographic restrictions stated; examples show US-based awardees
Other requirements
- Academic institutions worldwide
Overview
Program Overview
The Mark Foundation for Cancer Research is dedicated to accelerating exciting academic discoveries into new therapies and platforms that will substantially improve outcomes for cancer patients. The Drug Discovery Award program addresses the gap of limited resources for academic scientists to advance drug discovery efforts for promising new cancer targets.
Focus
Through this program, The Mark Foundation aligns with investigators working to:
- Discover and progress a new therapeutic agent into preclinical development
- Advance post-target validation through early lead development
- Receive expertise of seasoned biopharma R&D scientists who advise on activities on the critical path to developing a new therapeutic agent
Geographic Scope
No geographic restrictions stated; examples show US-based awardees
What They Support
- Resources to support post-target validation through early lead development
- Expertise and mentoring from seasoned biopharma R&D scientists
- Projects focused on converting promising scientific discoveries into therapeutics
Contact Information
- Phone: 646-866-5950
- Email: info@themarkfoundation.org
- Address: 1350 6th Ave, New York, NY 10019
What The Mark Foundation for Cancer Research (US) Ltd actually gave
Source: IRS Form 990, 2024
- Grants in 2024
- 29
- Total given
- $19.49M
- Median grant
- $500K
- Range
- $11K–$2.75M
- By dollars: New York 32%, California 27%, Massachusetts 9%. Top recipient cities: New York, NY; Boston, MA; San Francisco, CA.
- 0% of grants with a stated purpose were for general or operating support.
- 21% of recipients were new grantees, not repeat recipients.
Example grants
The Trustees of Columbia University in the City of New York · New York, NY
Research
$2.75M
Regents of the University of California San Francisco · San Francisco, CA
Research
$2.3M
Memorial Sloan Kettering Cancer Center · New York, NY
Research
$1.57M
Johns Hopkins University · Baltimore, MD
Research
$1.38M
The Salk Institute for Biological Studies · La Jolla, CA
Research
$1M
Focus Areas & Funding Uses
Fields of Work
- Cancer
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Endeavor Award
The Mark Foundation for Cancer Research (US) Ltd
Amount
Varies
Deadline
Deadline not published
ASPIRE Award
The Mark Foundation for Cancer Research (US) Ltd
Amount
Varies
Deadline
Deadline not published
Emerging Leader Award Grant
The Mark Foundation for Cancer Research (US) Ltd
Amount
Varies
Deadline
Deadline not published
Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)
National Institutes of Health
Amount
$3,400,000 total
Deadline
November 23, 2026
Discovery of the Genetic Basis of Childhood Cancers and of Congenital Anomalies: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
January 11, 2027
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Up to $350,000
Deadline
November 6, 2026
Ready to apply for Drug Discovery Award?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Drug Discovery Award. Now let's win it.